NCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
26 trialsNCT04369560 2025-12-17
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
University of Pittsburgh
Phase EARLY_PHASE1 Recruiting
NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT06116253 2025-06-24
Advanced Diffusion Imaging in Renal Cancer Patients
NYU Langone Health
Phase NA Recruiting
NCT04685928 2025-05-06
SMART
Chinese University of Hong Kong
Phase NA Completed
NCT06280781 2025-01-24
IP9-ATLAS
Imperial College London
Phase NA Recruiting
NCT02163317 2024-05-10
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT06185478 2023-12-29
Prostate Diffusion Imaging With Distortion Correction
Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase NA Suspended
NCT03987568 2022-12-21
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT05603351 2022-11-02
ProstaPilot
Masaryk Memorial Cancer Institute
Phase NA Unknown
NCT02681614 2022-06-30
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
Case Comprehensive Cancer Center
Phase NA Completed
NCT03238170 2022-03-18
FIMRA-P
Guy's and St Thomas' NHS Foundation Trust
Phase NA Unknown
NCT03436901 2022-01-03
TENY
Aarhus University Hospital
Phase NA Completed
NCT04803188 2021-03-17
ProSa-I
University of Roma La Sapienza
Phase NA Unknown
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT02911467 2020-07-24
MR
University of California, San Francisco
Phase 1 Terminated
NCT02662166 2020-06-17
MIB
Turku University Hospital
Phase NA Completed
NCT02488096 2020-01-21
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
Saskatchewan Health Authority - Regina Area
Phase NA Completed
NCT02470910 2019-12-11
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Dana-Farber Cancer Institute
Phase NA Completed
NCT02141490 2019-09-06
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02786459 2019-06-03
ProxiScan
University Health Network, Toronto
Phase NA Completed
NCT00851682 2018-10-31
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Washington University School of Medicine
Phase NA Terminated
NCT03409029 2018-01-30
A Study Using MRI To Assess Bladder Motion During Radiotherapy
The Christie NHS Foundation Trust
Phase NA Unknown
NCT01357512 2017-12-02
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
University of Oulu
Phase NA Completed
NCT02516995 2016-02-10
FIBROP
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed